149 related articles for article (PubMed ID: 1636280)
1. [Antibodies to neutrophilic granulocytes (p-ANCA): a further indication for a common origin of ulcerative colitis and primary sclerosing cholangitis?].
Jahn HU; Zeitz M
Z Gastroenterol; 1992 Jun; 30(6):441-2. PubMed ID: 1636280
[No Abstract] [Full Text] [Related]
2. [Autoantibodies in chronic inflammatory bowel diseases: more than an epiphenomenon?].
Folwaczny C; Fricke H
Z Gastroenterol; 1998 Jan; 36(1):105-8. PubMed ID: 9531690
[No Abstract] [Full Text] [Related]
3. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
[TBL] [Abstract][Full Text] [Related]
4. Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis, ulcerative colitis, and autoimmune diseases.
Tervaert JW; Mulder AH; Horst G; Haagsma EB; Kleibeuker JH; Kallenberg CG
Gastroenterology; 1992 Mar; 102(3):1090-1. PubMed ID: 1537508
[No Abstract] [Full Text] [Related]
5. [Anticytoplasmic auto-antibodies of polynuclear neutrophils: a common biologic marker in hemorrhagic rectocolitis and primary sclerosing cholangitis].
Jacquot S
Gastroenterol Clin Biol; 1991; 15(12):990-1. PubMed ID: 1783264
[No Abstract] [Full Text] [Related]
6. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis.
Duerr RH; Targan SR; Landers CJ; LaRusso NF; Lindsay KL; Wiesner RH; Shanahan F
Gastroenterology; 1991 May; 100(5 Pt 1):1385-91. PubMed ID: 2013383
[TBL] [Abstract][Full Text] [Related]
7. Absence of antineutrophil cytoplasmic antibodies in relatives of UK patients with primary sclerosing cholangitis and ulcerative colitis.
Bansi DS; Lo S; Chapman RW; Fleming KA
Eur J Gastroenterol Hepatol; 1996 Feb; 8(2):111-6. PubMed ID: 8723413
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis.
Seibold F; Slametschka D; Gregor M; Weber P
Gastroenterology; 1994 Aug; 107(2):532-6. PubMed ID: 8039629
[TBL] [Abstract][Full Text] [Related]
9. Segregation of pANCA antigenic recognition by DNase treatment of neutrophils: ulcerative colitis, type 1 autoimmune hepatitis, and primary sclerosing cholangitis.
Vidrich A; Lee J; James E; Cobb L; Targan S
J Clin Immunol; 1995 Nov; 15(6):293-9. PubMed ID: 8576315
[TBL] [Abstract][Full Text] [Related]
10. Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis, ulcerative colitis, and autoimmune diseases.
Zauli D; Baffoni L; Cassani F; Fusconi M; Lenzi M; Ballardini G; Luigi M; Bianchi FB; Schrumpf E
Gastroenterology; 1992 Mar; 102(3):1088-90. PubMed ID: 1537507
[No Abstract] [Full Text] [Related]
11. Neutrophil cytoplasmic autoantibodies after liver transplantation in patients with primary sclerosing cholangitis.
Haagsma EB; Mulder AH; Gouw AS; Horst G; Meerman L; Slooff MJ; Kallenberg CG
J Hepatol; 1993 Aug; 19(1):8-14. PubMed ID: 8301047
[TBL] [Abstract][Full Text] [Related]
12. Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease.
Peen E; Almer S; Bodemar G; Rydén BO; Sjölin C; Tejle K; Skogh T
Gut; 1993 Jan; 34(1):56-62. PubMed ID: 8432453
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases.
Mulder AH; Horst G; Haagsma EB; Limburg PC; Kleibeuker JH; Kallenberg CG
Hepatology; 1993 Mar; 17(3):411-7. PubMed ID: 8444414
[TBL] [Abstract][Full Text] [Related]
14. The enigma of anti-neutrophil antibodies in ulcerative colitis primary sclerosing cholangitis: important genetic marker or epiphenomenon?
Chapman RW
Hepatology; 1995 May; 21(5):1473-4. PubMed ID: 7737656
[No Abstract] [Full Text] [Related]
15. The immunogenetic basis for anti-neutrophil cytoplasmic antibody production in primary sclerosing cholangitis and ulcerative colitis.
Mehal WZ; Lo SK; Chapman RW; Fleming KA
J Hepatol; 1994 Nov; 21(5):910-1. PubMed ID: 7890911
[No Abstract] [Full Text] [Related]
16. [Primary sclerosing cholangitis].
Hauschild S; Gross WL
Dtsch Med Wochenschr; 1992 Jan; 117(5):197-8. PubMed ID: 1735382
[No Abstract] [Full Text] [Related]
17. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis.
Seibold F; Weber P; Klein R; Berg PA; Wiedmann KH
Gut; 1992 May; 33(5):657-62. PubMed ID: 1612483
[TBL] [Abstract][Full Text] [Related]
18. [ANCA (antineutrophil cytoplasm antibodies)].
Katz S
Acta Gastroenterol Latinoam; 1994; 24(1):61-3. PubMed ID: 8059593
[No Abstract] [Full Text] [Related]
19. Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease.
Kossa K; Coulthart A; Ives CT; Pusey CD; Hodgson HJ
Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):783-9. PubMed ID: 7496870
[TBL] [Abstract][Full Text] [Related]
20. Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis.
Halbwachs-Mecarelli L; Nusbaum P; Noël LH; Reumaux D; Erlinger S; Grünfeld JP; Lesavre P
Clin Exp Immunol; 1992 Oct; 90(1):79-84. PubMed ID: 1327593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
